Corteva, Inc. $CTVA Shares Acquired by NEOS Investment Management LLC

NEOS Investment Management LLC lifted its position in shares of Corteva, Inc. (NYSE:CTVA) by 13.3% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 109,340 shares of the company’s stock after acquiring an additional 12,819 shares during the quarter. NEOS Investment Management LLC’s holdings in Corteva were worth $9,260,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. EFG International AG acquired a new position in Corteva in the 2nd quarter worth about $25,000. Compass Financial Management LLC acquired a new stake in Corteva in the second quarter valued at approximately $25,000. JPL Wealth Management LLC purchased a new stake in shares of Corteva in the third quarter valued at approximately $25,000. Garton & Associates Financial Advisors LLC acquired a new position in shares of Corteva during the 4th quarter worth approximately $27,000. Finally, Bank of Jackson Hole Trust purchased a new position in shares of Corteva during the 4th quarter valued at approximately $28,000. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Corteva Price Performance

CTVA stock opened at $87.78 on Friday. Corteva, Inc. has a 1 year low of $60.53 and a 1 year high of $90.97. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10. The firm has a market capitalization of $58.57 billion, a PE ratio of 58.13, a price-to-earnings-growth ratio of 2.70 and a beta of 0.57. The business has a 50 day simple moving average of $83.42 and a 200-day simple moving average of $81.00.

Corteva (NYSE:CTVA) last announced its quarterly earnings data on Thursday, July 30th. The company reported $2.30 EPS for the quarter, topping analysts’ consensus estimates of $2.24 by $0.06. The firm had revenue of $6.38 billion for the quarter, compared to the consensus estimate of $6.60 billion. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The firm’s revenue was down 1.2% compared to the same quarter last year. During the same quarter last year, the business posted $2.20 earnings per share. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Equities research analysts anticipate that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be issued a $0.18 dividend. The ex-dividend date of this dividend is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.8%. Corteva’s dividend payout ratio is currently 47.68%.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on CTVA. JPMorgan Chase & Co. lifted their price target on shares of Corteva from $77.00 to $83.00 and gave the company a “neutral” rating in a research note on Monday, August 3rd. Bank of America increased their price objective on shares of Corteva from $90.00 to $96.00 and gave the company a “buy” rating in a report on Monday, July 20th. UBS Group dropped their target price on shares of Corteva from $89.00 to $85.00 and set a “neutral” rating on the stock in a research report on Tuesday, August 18th. Weiss Ratings downgraded shares of Corteva from a “hold (c+)” rating to a “hold (c)” rating in a research report on Monday, August 3rd. Finally, Oppenheimer raised their price target on shares of Corteva from $89.00 to $95.00 and gave the company an “outperform” rating in a research note on Thursday, July 23rd. Fourteen research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $91.50.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.